BLBAUPOST GROUP LLC/MA
Led by Seth Klarman · Portfolio as of Q1 2024
Top Holdings22 positions
LIBERTY GLOBAL LTD | 42.3M | $746.4M | 20.4% | $9.76 | -5.33% | 2 qtrssince 2023-Q4 | Unchanged 0 |
ALPHABET INC | 3M | $450.3M | 12.3% | $94.12 | +60.25% | 17 qtrssince 2020-Q1 | Increased 62 |
WILLIS TOWERS WATSON PLC LTD | 1.6M | $427.8M | 11.7% | $205.73 | +29.64% | 13 qtrssince 2021-Q1 | Unchanged 0 |
FIDELITY NATL INFORMATION SV | 5.6M | $413.8M | 11.3% | $54.18 | +32.12% | 7 qtrssince 2022-Q3 | Decreased 0 |
VIASAT INC | 15M | $271.9M | 7.4% | $54.30 | -66.68% | 22 qtrssince 2018-Q4 | Decreased 0 |
CRH PLC | 2.7M | $233.7M | 6.4% | $51.77 | +61.58% | 3 qtrssince 2023-Q3 | Decreased 0 |
CLARIVATE PLC | 30.6M | $227.3M | 6.2% | $7.08 | +4.94% | 3 qtrssince 2023-Q3 | Increased 72 |
LIBERTY MEDIA CORP DEL | 4.4M | $129.3M | 3.5% | — | — | 3 qtrssince 2023-Q3 | Decreased 0 |
LIBERTY GLOBAL LTD | 7.2M | $121.7M | 3.3% | $9.16 | -4.80% | 2 qtrssince 2023-Q4 | Unchanged 0 |
| 118M | $102.6M | 2.8% | — | — | — | New 79 | |
JAZZ PHARMACEUTICALS PLC | 833,696 | $100.4M | 2.7% | $135.74 | -11.29% | 5 qtrssince 2023-Q1 | Unchanged 0 |
LIBERTY MEDIA CORP DEL | 2.7M | $79.5M | 2.2% | — | — | 3 qtrssince 2023-Q3 | Decreased 0 |
JACOBS SOLUTIONS INC | 506,786 | $77.9M | 2.1% | $108.98 | +14.86% | 3 qtrssince 2023-Q3 | Decreased 0 |
EAGLE MATLS INC | 262,000 | $71.2M | 2.0% | $268.67 | 0.00% | 1 qtr | New 69 |
THERAVANCE BIOPHARMA INC | 6.6M | $59.1M | 1.6% | $18.32 | -51.03% | 22 qtrssince 2018-Q4 | Decreased 0 |
WESCO INTL INC | 205,724 | $35.2M | 1.0% | $167.69 | 0.00% | 1 qtr | New 57 |
WARNER BROS DISCOVERY INC | 3.7M | $32.4M | 0.9% | $12.40 | +149.68% | 8 qtrssince 2022-Q2 | Decreased 0 |
HERBALIFE LTD | 2.2M | $22.6M | 0.6% | $13.66 | -26.45% | 6 qtrssince 2022-Q4 | Increased 53 |
GDS HLDGS LTD | 2.6M | $17.3M | 0.5% | $6.65 | 0.00% | 1 qtr | New 48 |
ALTICE USA INC | 4.8M | $12.5M | 0.3% | $4.33 | -78.53% | 6 qtrssince 2022-Q4 | Unchanged 0 |
BAUPOST GROUP LLC/MA manages $3.7B across 22 positions as of Q1 2024. Top holdings: LBTYK (20.4%), GOOG (12.3%), WTW (11.7%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 4.5/5.0.
Active quarter - 6 new positions, 7 exits, 3 increased. Top move: CLVT (INCREASED, conviction 72). Portfolio: $3.7B across 22 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR